Preclinical Study of a COVID-19 Vaccine Candidate Based on a Next-Generation Korean Self-Amplifying RNA (saRNA) Platform
11:30 am - Thursday 12th November 2026
- Exploring immunogenicity and protective efficacy of a next-generation self-amplifying RNA COVID-19 vaccine candidate
- Discussing biodistribution and nonclinical safety assessment supporting preclinical development
- Unveiling CMC development and process optimization toward clinical translation
